B-cell linker protein prevents aneuploidy by inhibiting cytokinesis

Cancer Science

Volumn 99, Issue 12, 2008, Pages 2444-2454

  Kamino, Hiroki ^a   Futamura, Manabu ^a   Nakamura, Yasuyuki ^a   Kitamura, Noriaki ^a   Kabu, Koki ^a   Arakawa, Hirofumi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; B CELL LINKER PROTEIN; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; CYTOKINESIS; DNA DAMAGE; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TETRAPLOIDY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANEUPLOIDY; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOKINESIS; HCT116 CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; MODELS, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 57349120148     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00990.x     Document Type: Article

References (36)

1. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-10.
2. Vousden KH. Live or let die: The cell's response to p53. Nat Rev Cancer 2002; 2: 594-604.
3. Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci 2004; 95: 7-11.
4. Arakawa H. p53, apoptosis and axon-guidance molecules. Cell Death Differ 2005; 12: 1057-65.
5. Liu G, Parant JM, Lang G et al. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 2004; 36: 63-8.
6. Barboza JA, Liu G, Ju Z, El-Naggar AK, Lozano G. p21 delays tumor onset by preservation of chromosomal stability. Proc Natl Acad Sci USA 2006; 103: 19 842-7.
7. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: Aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5: 773-85.
8. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432: 338-41.
9. Margolis RL. Tetraploidy and tumor development. Cancer Cell 2005; 8: 353-4.
10. Margolis RL, Lohez OD, Andreassen PR. G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 2003; 88: 673-83.
11. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 2001; 12: 1315-28.
12. Andreassen PR, Lacroix FB, Lohez OD, Margolis RL. Neither p21 WAF1 nor 14-3-3σ prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21 WAF1 induces stable G1 arrest in resting tetraploid cells. Cancer Res 2001; 61: 7660-8.
13. Fu C, Turck CW, Kurosaki T, Chan AC. BLNK: A central linker protein in B cell activation. Immunity 1998; 9: 93-103.
14. Wienands J, Schweikert J, Wollscheid B et al. SLP-65: A new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J Exp Med 1998; 188: 791-5.
15. Goitsuka R, Fujimura Y, Mamada H et al. BASH, a novel signaling molecule preferentially expressed in B cells of the brusa of Fabricius. J Immunol 1998; 161: 5804-8.
16. Kurosaki T. Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol 1999; 17: 555-92.
17. Ishiai M, Kurosaki M, Pappu R et al. BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity 1999; 10: 117-25.
18. Flemming A, Brummer T, Reth M, Jumaa H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol 2003; 4: 13-5.
19. Jumaa H, Bossaller L, Portugal K et al. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukemia. Nature 2003; 423: 452-6.
20. Hayashi K, Yamamoto M, Nojima T, Goitsuka R, Kitamura D. Distinct signaling requirements for Dmu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors. Immunity 2003; 18: 825-36.
21. Piekny A, Werner M, Glotzer M. Cytokinesis: Welcome to the Rho zone. Trends Cell Biol 2005; 15: 651-8.
22. Straight AF, Field CM. Microtubules, membrane and cytokinesis. Curr Biol 2000; 10: R760-70.
23. Masuda Y, Futamura M, Kamino H et al. The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage. J Hum Genet 2006; 51: 652-64.
24. Shi Q, King RW. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 2005; 437: 1038-42.
25. Bhonde MR, Hanski ML, Notter M et al. Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth. Oncogene 2006; 25: 165-75.
26. Takahashi A, Ohtani N, Yamakoshi K et al. Mitogenic signalling and the p16INF4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 2006; 8: 1291-7.
27. Shimo A, Nishidate T, Ohta T et al. Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells. Cancer Sci 2007; 98: 174-81.
28. Kanehira M, Katagiri T, Shimo A et al. Oncogenic role of MPHOSPH1, a candidate-testis antigen specific to human bladder cancer. Cancer Res 2007; 67: 3276-85.
29. Hayama S, Daigo Y, Yamabuki T et al. Phosphorylation and activation of cell division associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis. Cancer Res 2007; 67: 4113-22.
30. Vishioni B, Oudejans JJ, Vos W, Rodriguez JA, Giaccone G. Frequent overexpression of aurora B kinase, a novel drug target, in non-small lung carcinoma patients. Mol Cancer Ther 2006; 5: 2905-13.
31. Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004; 4: 927-36.
32. Carvajal RD, Tse A, Schwartz GK. Aurora kinases: New targets for cancer therapy. Clin Cancer Res 2006; 12: 6869-75.
33. Yoshizaki H, Ohba Y, Kurokawa K et al. Activity of Rho-family GTPase during cell division as visualized with FRET-based probes. J Cell Biol 2003; 162: 223-32.
34. Jiang W, Jimenez G, Wells NJ et al. PRC1: A human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell 1998; 2: 877-85.
35. Minoshima Y, Kawashima T, Hirose K et al. Phosphorylation by Aurora B converts MgcRacGAP to a RhoGAP during cytokinesis. Dev Cell 2003; 4: 549-60.
36. Nigg EA. Polo-like kinases: Positive regulators of cell division from start to finish. Curr Opin Cell Biol 1998; 10: 776-83.